Search Within

Weinberg Fellows

  1. "Anita Kumar"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (26)
  3. Research Letter (4)
  4. Review (2)
  5. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (82)
  2. Department of Medicine (82)
  3. Hematologic Malignancies, Division of (82)
  4. Hematology-Oncology Fellows (82)
  5. Lymphoma (82)
  6. Population Sciences Research Program (57)

More Groups

People
  1. Anita Kumar (82)
  2. Andrew Zelenetz (70)
  3. Colette Owens (62)
  4. Maria Palomba (61)
  5. Ariela Noy (59)
  6. Paul Hamlin (59)

More People

Years
  1. 2025 (7)
  2. 2024 (21)
  3. 2023 (18)
  4. 2022 (7)
  5. 2021 (12)
  6. 2020 (11)

More Years

Publications
  1. Blood (46)
  2. Blood Advances (6)
  3. Blood Cancer Journal (5)
  4. Haematologica (4)
  5. Hematological Oncology (4)
  6. Leukemia and Lymphoma (4)

More Publications

Publishers
  1. American Society of Hematology (52)
  2. Nature Publishing Group (6)
  3. Ferrata Storti Foundation (4)
  4. Taylor & Francis Group (4)
  5. Wiley Blackwell (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
    Correspondence

    Cassanello, G.; Drill, E.; Qiu, A.; Ewalt, M. D.; Hamlin, P.; Horwitz, S. M.; Joffe, E.; Kumar, A.; Moskowitz, A. J.; Noy, A.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Correlation between TP53 mutational status and digital quantification of p53 immunohistochemistry in mantle cell lymphoma
    Journal Article

    Yan, M.; Sethi, S.; Epstein-Peterson, Z.; Kumar, A.; Dogan, A.; Galera, P.
    Virchows Archiv (2025)

    Fulltext@MSK | Save
  • Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
    Journal Article

    Luttwak, E.; Robin, E. T.; Drill, E.; Boardman, A.; Caron, P.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Predictors of outcomes with covalent BTK inhibitor treatment in relapsed/refractory TP53-mutant mantle cell lymphoma
    Research Letter

    Uppal, M.; Joseph, A.; Drill, E.; Hamlin, P.; Falchi, L.; Noy, A.; Owens, C.; Epstein-Peterson, Z. D.; Salles, G.; Zelenetz, A. D.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: Real-life experience
    Journal Article

    Cassanello, G.; Drill, E.; Rivas-Delgado, A.; Okwali, M.; Isgor, I.; Caron, P. C.; Epstein-Peterson, Z.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
    Journal Article

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chhabra, S.; Chabowska, M.; Dogan, A.; Falchi, L.; Grieve, C.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas
    Journal Article

    Ghione, P.; Bantilan, K. S.; Joffe, E.; Palomba, M. L.; Noy, A.; Caron, P.; Hamlin, P.; Kumar, A.; Matasar, M.; Owens, C.; more...
    Blood Neoplasia (2024)

    Fulltext@MSK | Save
  • Two decade single institution experience highlights rare survivors with relapsed or refractory Burkitt lymphoma
    Meeting Abstract

    Molla, R.; Berman, E.; Caron, P.; Donnelly, G.; Falchi, L.; Hamlin, P. A.; Horwitz, S.; Intlekofer, A. M.; Johnson, W. T.; Jurcic, J. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Sequential R-CHOP/(R)-ICE and dose-adjusted EPOCH-R are both appropriate frontline treatments for newly diagnosed primary mediastinal B-cell lymphoma: Results of a retrospective analysis
    Meeting Abstract

    Bantilan, K. S.; Luttwak, E.; Moskowitz, C. H.; Matasar, M.; Straus, D. J.; Portlock, C. S.; Moskowitz, A.; Noy, A.; Palomba, M. L.; Horwitz, S.; more...
    Blood (2024)

    Fulltext@MSK | Save